F. del Valle

Gene mutations and response to treatment with all-trans retinoic acid in elderly patients with acute myeloid leukemia. Results from the AMLSG Trial AML HD98B

Richard F. Schlenk, Konstanze Döhner, Michael Kneba et al. · Haematologica · 2008 · 209 citations · Full text

Medicine, Molecular Genetics, Oncology +13

Phase III study of all-trans retinoic acid in previously untreated patients 61 years or older with acute myeloid leukemia

Richard F Schlenk, Stefan Fröhling, Frank Hartmann et al. · Leukemia · 2004 · 170 citations

Medicine, Hematology, Oncology +5

Risk-adapted postremission therapy in acute myeloid leukemia: results of the german multicenter AML HD93 treatment trial

Richard F. Schlenk, Axel Benner, Frank Hartmann et al. · Leukemia · 2003 · 121 citations

Medicine, Hematology, Oncology +12

Mitoxantrone/high-dose ara-c and recombinant human gm-csf in the treatment of refractory non-hodgkin's lymphoma a pilot study

Anthony D. Ho, F. del Valle, M. Engelhard et al. · Cancer · 1990 · 39 citations · Full text

Medicine, Oncology, Pharmacotherapy +16

Dose-dependent effect of etoposide in combination with busulfan plus cyclophosphamide as conditioning for stem cell transplantation in patients with acute myeloid leukemia

Nicolaus Kröger, Tatjana Zabelina, S. Sonnenberg et al. · Bone Marrow Transplantation · 2000 · 28 citations

Medicine, Hematology, Oncology +15